For Immediate Release Contact marketingcommunications@us.medical.canon
September 21, 2009
SAN FRANCISCO, Sept. 21, 2009 – To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba’s Infinix™-i systems with mid (12” x 12”) and large (12” x 16”) flat-panel detectors (FPD). Toshiba will demonstrate its low-contrast imaging capabilities at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).
“Toshiba’s low-contrast imaging enables better visualization of soft tissue to improve the imaging and treatment of patients,” said Robert Micer, director, X-ray Vascular Business Unit, Toshiba. “Using low-contrast imaging in the angio suite improves patient safety and diagnostic confidence by offering CT-like images of soft tissue, including brain tissue, cerebral ventricles and hepatic visualization, without requiring additional exams.”
Beneficial for both physicians and patients, low-contrast imaging allows better visualization of soft tissue in the angiography suite and enables more accurate diagnosis of a variety of diseases using a single system. Additionally, this technology may be used to confirm appropriate endpoints during interventional procedures, such as aortic stent-grafting. Capturing CT-like images without the use of an additional test helps improve accuracy and workflow in the angio suite. It also leads to lowering overall health care costs by using a single system to treat numerous diseases and handle multiple procedures.
The Infinix-i line features a five-axis C-arm that enables head-to-toe and fingertip-to-fingertip coverage and allows greater clinician access to the patient for diagnostic and interventional procedures. The freely moving components, ergonomically friendly design and five-axis positioner enable physicians to obtain optimal angles for cardiac diagnosis and interventional procedures without repositioning the patient. Infinix’s unique, flexible design improves workflow and collaboration between cardiologists, interventional cardiologists, anesthesiologists and clinical staff during exams, especially in hybrid OR settings.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 198,000 employees worldwide and annual sales of $77 billion. For more information, visit www.medical.toshiba.com.